Filing Details
- Accession Number:
- 0001415889-25-008171
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-14 21:35:21
- Reporting Period:
- 2025-03-12
- Filing Date:
- 2025-03-14
- Accepted Time:
- 2025-03-14 21:35:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1646382 | Matthew Rabinowitz | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | Executive Chairman | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-12 | 2,893 | $0.00 | 2,415,415 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-03-14 | 1,000 | $145.37 | 2,414,415 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-14 | 4,798 | $146.58 | 2,409,617 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-14 | 29,967 | $147.64 | 2,379,650 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-14 | 13,935 | $148.38 | 2,365,715 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-14 | 300 | $149.00 | 2,365,415 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 84,000 | Indirect | By spouse |
Footnotes
- Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance.
- Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.00 to $145.88 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.01 to $146.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.01 to $148.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.01 to $148.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
